Lyell Immunopharma, Inc. (LYEL)

23.95 +0.05 (+0.21%) USD  |  NASDAQ  |  Jan 21, 16:00
23.95 0.00 (0.00%) After-Hours: 20:00
More

Lyell Immunopharma Net Total Long Term Debt (Quarterly)

Net Total Long Term Debt (Quarterly) Chart

View Net Total Long Term Debt (Quarterly) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Total Long Term Debt (Quarterly) Range, Past 5 Years

View Net Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Total Long Term Debt (Quarterly) Benchmarks

View Net Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade